Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era.

Huang, Chung-Feng; Awad, Manar Hijaze; Gal-Tanamy, Meital; Yu, Ming-Lung.

Afiliação

Huang CF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital; College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Awad MH; Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Gal-Tanamy M; Ph.D. Program in Translational Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, and Academia Sinica, Taiwan.
Yu ML; Molecular Virology Lab, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Clin Mol Hepatol ; 2024 Jul 01.

Article em En | MEDLINE | ID: mdl-38946463

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article